A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Diltiazem D4 | CAS 112259-41-3 - Request Quote

Picture of Diltiazem D4

Diltiazem D4

SZ CAT No:SZ-D029D01
CAS No
112259-41-3
Mol.F.
C22H22D4N2O4S
Mol.Wt.
418.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Diltiazem D4 is chemically (2S,3S)-5-(2-(Dimethylamino)ethyl-1,1,2,2-d4)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate. Diltiazem D4 is supplied with detailed characterization data compliant with regulatory guideline. Diltiazem D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Diltiazem.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 112259-41-3

Purchase 112259-41-3

Order 112259-41-3

Enquire 112259-41-3

price of 112259-41-3

112259-41-3 Supplier

112259-41-3 Manufacturer

112259-41-3 Exporter

buy high quality Diltiazem D4

Purchase Diltiazem D4

Diltiazem D4 suppliers

Diltiazem D4 manufacturers

Diltiazem D4 price

Order Diltiazem D4

Enquire Diltiazem D4

Diltiazem D4 cost

Diltiazem D4 Supplier

Diltiazem D4 Distributor

Diltiazem D4 for Method Validation

Diltiazem Reference Standard

Diltiazem D4 for ANDA Filing

Diltiazem D4 for Forced Degradation Studies

Diltiazem D4 Identification Standards

Diltiazem D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,